Bone mineral content and bone mineral metabolism: Changes after growth hormone treatment in juvenile chronic arthritis

Journal of Rheumatology

Volumn 27, Issue 4, 2000, Pages 1073-1081

  Rooney, Madeleine ^b   Davies, Ursula M ^b   Reeve, Jonathan ^b   Preece, Michael ^b   Ansell, Barbara M ^b   Woo, Patricia M M ^a  

^a Windeyer Institute of Medical Sciences   (United Kingdom)

^b NONE

Author keywords

Bone metabolism; Bone mineral content; Growth hormone; Juvenile chronic arthritis; Osteoporosis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; OSTEOCALCIN; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CHILD; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; INTESTINE ABSORPTION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OSTEOPOROSIS; PRIORITY JOURNAL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; C-REACTIVE PROTEIN; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; NUTRITION ASSESSMENT; OSTEOCALCIN; OSTEOPOROSIS; PREDNISOLONE; PREGNENEDIONES; VITAMIN D;

EID: 0034040794     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kanzaki S, Hosoda K, Moriwake T, et al. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992;75:1104-9.
2. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C. Serum bone G1a protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab 1990;71:122-6.
3. Sartorio A, Conti A, Guzzaloni G, Faglia G. Serum osteocalcin levels in patients with GH deficiency before and during GH treatment. Acta Pediatr Scand 1991;80:100-2.
4. Henneman PH, Forber AB, Modawer M, Dempsey EF, Conor EL. Effects of human growth hormone in man. J Clin Invest 1960;39:1223-38.
5. Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CY. Effect of growth hormone administration: reciprocal changes in serum 1 alpha, 25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab 1980;51:321-4.
6. Burstein S, Chen IW, Tsang RC. Effects of growth hormone replacement therapy on 1,25 dihydroxyvitamin D and calcium metabolism. J Clin Endocrinol Metab 1983;56:1246-51.
7. Greig F, Avruskin TW, Greenfield E, Prasad V, Bastian W, Castells S. Changes in bone density in children during treatment with growth hormone [abstract]. Hormone Res 1989;31 Suppl:20.
8. Zamboni G, Antoniazzi F, Radetti G, Musumeci D, Tato L. Effects of two different regimens of recombinant growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr 1991;119:483-5.
9. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. Effects of long term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993;122:37-45.
10. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Bone mineral status in growth hormone deficiency. J Pediatr 1980;96:393-6.
11. Kaufman JM, Vandewegle H, Tadman P, Cram R. Bone mineral status in Gh deficient male patients with isolated and multiple deficiencies [abstract]. Hormone Res 1989;31 Suppl 1:21.
12. Hauschka PV, Lian JB, Cole DEC, Gundberg CM. Osteocalcin and matrix G1a protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
13. Laaksonen AL. A prognostic study of juvenile rheumatoid arthritis: analysis of 544 cases. Acta Pediatr Scand 1966;55 Suppl 166:s9-91.
14. Bacon MC, White P. A new approach to the assessment of growth in JRA [abstract]. Arthritis Rheum 1987;Suppl 30:5192.
15. Lovell D, Gregg D, Heubi J, Levinson J. Bone mineralization in JRA patients [abstract]. Arthritis Rheum 1986;Suppl 67:29.
16. Warady DB, Lindsley CB, Lukert BP, Robinson RC. Calcium and vitamin D supplementation in pediatric osteoporotic patients with rheumatic disease [abstract]. Arthritis Rheum 1989;Suppl 32:29.
17. Reed A, Haugen M, Pachman L, Langman CB. 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. J Pediatr 1991;119:657-60.
18. Bardare M, Bianchi ML, Furia M, Gandolini GG, Cohen E, Montesano A. Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids. Clin Exp Rheumatol 1991;Suppl 6:29-31.
19. Hopp R, Degan J, Callagher JC, Cassidy JT. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J Rheumatol 1991;18:1235-9.
20. Ansell BM, Bywaters EGL. Growth in Still's disease. Ann Rheum Dis 1956;15:295-318.
21. Bacon MC, White PH, Raiten DJ, et al. Nutritional status and growth in juvenile rheumatoid arthritis. Semin Arthritis Rheum 1990;20:97-106.
22. Bernstein BH, Stobie D, Singsen BH, et al. Growth retardation in juvenile rheumatoid arthritis. Arthritis Rheum 1977;20 Suppl 2:212-6.
23. Varonos S, Ansell BM, Reeve J. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int 1987;41:75-8.
24. Hillman L, Cassidy JT, Johnson L, Lee D, Allen SH. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Paediatr 1994;124:910-6.
25. Stapleton FB, Hanissian AS, Miller LA. Hypercalciuria in children with juvenile rheumatoid arthritis: association with hematuria. J Paediatr 1985;107:235-9.
26. Abrams SA, Lipnick RN, Vieria NE, Stuff JE, Vergey AL. Calcium absorption and metabolism in children with juvenile rheumatoid arthritis assessed using stable isotopes. J Rheumatol 1993;20:1196-200.
27. Davies UM, Rooney M, Preece MA, Ansell BM, Woo P. Treatment of growth retardation in juvenile chronic arthritis with recombinant growth hormone. J Rheumatol 1994;21:153-8.
28. Davies UM, Jones J, Reeve J, et al. Juvenile chronic arthritis: effects of disease activity and recombinant growth hormone on insulin like growth factor-1, insulin like growth factor binding protein 1 and 3, insulin and osteocalcin. Arthritis Rheum 1997;40:332-40.
29. Wood PHN. Nomenclature and classification of arthritis in children. In: Munthe E, editor. The care of rheumatic children. Basel: EULAR Publishers; 1978:47-50.
30. Loftus J, Allen R, Hesp R, et al. Randomized double-blind trial of deflazacort vs. prednisolone in juvenile chronic (or rheumatoid) arthritis: a relatively bone sparing effect of deflazacort. Paediatrics 1991;88:428-36.
31. Darendilier F, Hindmarsh PC, Brook CDG. Dose response curves for treatment with biosynthetic growth hormone. J Endocrinol 1990;125:311-6.
32. Leitner C, editor. Body surface area. Geigy Scientific Tables, Vol. 1. 8th ed. Basle: Ciba-Geigy; 1981.
33. Ashby JP, Wright DJ, Rinsler M. The adjusted serum calcium concept - a reappraisal. Ann Clin Biochem 1986;23:533-7.
34. Morrell DJ, Dadi J, More J, et al. A monoclonal antibody to insulin-like growth factor-1 characterization, use in radioimmunoassay and effect on the biological activities of the growth factor. J Mol Endocrinol 1989;2:201-6.
35. Ashby JP, Newman DJ, Rinsler MG. Is intact PTH a sensitive biochemical indication of deranged calcium homeostasis in vitamin D deficiency? Ann Clin Biochem 1989;26:324-7.
36. Deacon AC, Hulme P, Hesp R, Green JR, Tellez M, Reeve J. Estimation of whole body absorption rate: a comparison of total urinary hydroxyproline excretion with 2 radioisotopic tracer methods in osteoporosis. Acta Clin Chem 1987;166:297-306.
37. David J, Loftus J, Hesp R, Ansell BM, Reeve J, Woo PMM. Spinal and somatic growth in patients with juvenile chronic arthritis treated for 2 years with deflazacort. Clin Exp Rheum 1992;10:621-4.
38. Kröger H, Kotaniemi A, Vainio P, et al. Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry [published erratum appears in Bone Miner 1992, 19:429]. Bone Miner 1992;17:75-85.
39. Pepmueller PH, Cassidy JT, Allen SH, Hillman LS. Bone mineralization and bone mineral metabolism in children with juvenile chronic arthritis. Arthritis Rheum 1996;39:746-57.
40. Hochberg Z, Amit T, Flyvbjerg A, Dorup I. Growth hormone (GH) receptor and Gh binding protein deficiency in the growth failure of potassium-depleted rats. J Endocrinol 1995;147:253-8.
41. Matkovic V, Fontana D, Tominac C. Goel P, Chesnut CH III. Factors that influence peak bone formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr 1990;52:878-88.
42. Bonjour J-P, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
43. Lloyd T, Rollings N, Andon MB, et al. Determinants of bone density in young women. I. Relationships among pubertal development, total body bone mass and total body bone density in premenarchal females. J Clin Endocrinol Metab 1992;75:383-7.